K-State licenses technology for coronavirus, norovirus compoundsMarch 2, 2020As global concerns surrounding the novel coronavirus COVID-19 continue to escalate, Kansas State University (K-State) has licensed a technology it says might lead to the production of an antiviral drug treatment.
SPONSORED CONTENTTake Control With ProHeart 12 (moxidectin)One dose offers year-long protection with a single injection, putting compliance in your hands. + Learn more